TY - CHAP AU - Horváth, Csaba AU - Takács, István ED - Takács, István TI - Kalcium-anyagcsere zavarai, osteoporosis T2 - Belgyógyászat 1 tantárgyi jegyzet PB - Semmelweis Kiadó CY - Budapest SN - 9789633316122 PY - 2024 SP - 170 EP - 185 PG - 16 UR - https://m2.mtmt.hu/api/publication/34817497 ID - 34817497 LA - Hungarian DB - MTMT ER - TY - CHAP AU - Takács, István ED - Takács, István TI - A mellékpajzsmirigy betegségei T2 - Belgyógyászat 1 tantárgyi jegyzet PB - Semmelweis Kiadó CY - Budapest SN - 9789633316122 PY - 2024 SP - 70 EP - 72 PG - 3 UR - https://m2.mtmt.hu/api/publication/34804137 ID - 34804137 LA - Hungarian DB - MTMT ER - TY - CHAP AU - Takács, István ED - Takács, István TI - Pajzsmirigyhormon-adaptációs szindróma (nonthyroidal illness – PASz) T2 - Belgyógyászat 1 tantárgyi jegyzet PB - Semmelweis Kiadó CY - Budapest SN - 9789633316122 PY - 2024 SP - 68 EP - 69 PG - 2 UR - https://m2.mtmt.hu/api/publication/34804134 ID - 34804134 LA - Hungarian DB - MTMT ER - TY - CHAP AU - Bakos, Bence AU - Takács, István ED - Takács, István TI - Hyperthyreosis T2 - Belgyógyászat 1 tantárgyi jegyzet PB - Semmelweis Kiadó CY - Budapest SN - 9789633316122 PY - 2024 SP - 46 EP - 49 PG - 4 UR - https://m2.mtmt.hu/api/publication/34803088 ID - 34803088 LA - Hungarian DB - MTMT ER - TY - BOOK ED - Takács, István TI - Belgyógyászat 1 tantárgyi jegyzet PB - Semmelweis Kiadó CY - Budapest PY - 2024 SP - 442 SN - 9789633316122 UR - https://m2.mtmt.hu/api/publication/34802851 ID - 34802851 N1 - Az e-könyv feltéve: 2024. április 14. LA - Hungarian DB - MTMT ER - TY - JOUR AU - Bojtor, Bence AU - Vaszilkó, Mihály Tamás AU - Ármós, Richárd Levente AU - Tóbiás, Bálint AU - Podani, János AU - Szentpéteri, Szófia Katalin AU - Balla, Bernadett AU - Lengyel, Balazs AU - Pikó, Henriett AU - Illés, Anett AU - Kiss, András AU - Putz, Zsuzsanna AU - Takács, István AU - Kósa, János AU - Lakatos, Péter TI - Analysis of SIRT1 Gene SNPs and Clinical Characteristics in Medication-Related Osteonecrosis of the Jaw JF - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES J2 - INT J MOL SCI VL - 25 PY - 2024 IS - 7 PG - 11 SN - 1661-6596 DO - 10.3390/ijms25073646 UR - https://m2.mtmt.hu/api/publication/34795043 ID - 34795043 AB - Certain genetic factors, including single-nucleotide polymorphisms (SNPs) in the SIRT1 gene, have been linked to medication-related osteonecrosis of the jaw (MRONJ). This study examined four SNPs in the SIRT1 gene and implemented multivariate statistical analysis to analyze genetic and clinical factors in MRONJ patients. Genomic DNA was isolated from peripheral blood samples of 63 patients of European origin treated for MRONJ, and four SNP genotypes in the gene encoding the SIRT-1 protein were determined by Sanger sequencing. The allele frequencies measured in the MRONJ population were compared with allele frequencies measured in the European population in the National Center for Biotechnology Information Allele Frequency Aggregator (NCBI ALFA) database. Genetic and clinical factors were examined with multivariate statistical analysis. A C:A allele distribution ratio of 77.8:22.2 was measured in the rs932658 SNP. In the ALFA project, a C:A allele distribution ratio of 59.9:40.1 was detected in the European population, which was found to be a significant difference (p = 4.5 × 10−5). Multivariate statistical analysis revealed a positive correlation (0.275) between the genotype of SNP rs932658 and the number of stages improved during appropriate MRONJ therapy. It is concluded that allele A in SNP rs932658 in the SIRT1 gene acts as a protective factor in MRONJ. LA - English DB - MTMT ER - TY - JOUR AU - Pikó, Henriett AU - Illés, Anett AU - Nagy, Sándor AU - Beke, Artúr AU - Árvai, Kristóf AU - Elekes, Tibor AU - Ferdinandyné Horváth, Emese AU - Ferenczy, Miklós AU - Mosonyi, Péter AU - Lukács, Valéria AU - Klujber, Valéria AU - Török, Olga AU - Kiss, Zsuzsanna AU - P Tardy, Erika AU - Tidrenczel, Zsolt AU - Tóbiás, Bálint AU - Balla, Bernadett AU - Lakatos, Péter AU - Kósa, János AU - Takács, István TI - Az első hazai tapasztalatok összegzése kromoszomális microarray-analízis és teljesexom-szekvenálás módszerekkel a magzati diagnosztikában JF - ORVOSI HETILAP J2 - ORV HETIL VL - 165 PY - 2024 IS - 14 SP - 523 EP - 530 PG - 8 SN - 0030-6002 DO - 10.1556/650.2024.33028 UR - https://m2.mtmt.hu/api/publication/34780698 ID - 34780698 AB - Bevezetés: Az elmúlt évtized egyik jelentős technológiai újdonsága az ún. ’high-throughput’ molekuláris genetikai vizsgálati módszerek – mint a kromoszomális microarray-analízis (chromosomal microarray analysis, CMA) és a teljesexom-szekvenálás (whole-exome sequencing, WES) – elterjedése a praenatalis diagnosztikában. Célkitűzés: Az elmúlt 5 évben munkacsoportunk több mint 252 praenatalis vizsgálatot végzett hazai laboratóriumi háttérrel, amelyek indikációját különböző súlyosságú strukturális magzati ultrahangeltérések képezték. A klasszikus citogenetikai vizsgálatok eredményétől függően végeztük el a nagy felbontású CMA- és WES-analíziseket a praenatalis diagnosztika érdekében. Módszer: A CMA-vizsgálatokat a „GeneChip System 3000 Instrument” platformmal végeztük az SNP-alapú komparatív hibridizálás módszerével. Az általunk elvégzett újgenerációs szekvenálás során a teljes humán exom szekvenciájának meghatározása IonTorrent és Illumina platformokkal történt. Eredmények: Összesen 252 magzati CMA-vizsgálatot végeztünk, és 42%-ban mutattunk ki valamilyen hiányt vagy többletet, ebből 22%-ban igazoltunk kóros eltérést. 42 esetben végeztünk WES-t, amelyből 9 esetben (21,4%) azonosítottunk kóros eltérést az öröklésmenetet támogató, a magzati fenotípussal feltételezhetően összefüggésben lévő, a ClinVar adatbázis vagy az ACMG-klasszifikáció alapján. Megbeszélés: Tekintettel arra, hogy a magzati fenotípus értékelése közvetett, a praenatalis CMA- és WES-elemzésnek elsősorban a magzati ultrahangvizsgálat során azonosítható strukturális anomáliákkal összefüggő génekre, kromoszomális régiókra kell korlátozódnia. A szülők vizsgálata mind a CMA-, mind a WES-analízisek során kiemelt jelentőséggel bír, főleg azokban az esetekben, amelyeknél a kapott eltérés nem hozható egyértelmű összefüggésbe az ultrahangeltérésekkel. Következtetés: Fontos meghatározni azokat a paramétereket, amelyek alapján a magzati mintában talált kópiaszám-eltéréseket és WES-vizsgálattal igazolt variánsokat a leletben közöljük (figyelembe véve a nemzetközi ajánlásokat). Ezek alapján a praenatalis klinikai genetikai tanácsadáskor sokkal használhatóbb információk adhatók. Orv Hetil. 2024; 165(14): 523–530. LA - Hungarian DB - MTMT ER - TY - JOUR AU - Takács, István AU - Mezősi, Emese AU - Soto, Alfonso AU - Kamenický, Peter AU - Figueres, Lucile AU - Galvez Moreno, Maria Angeles AU - Lemoine, Sandrine AU - Borson-Chazot, Francoise AU - Capel, Ismael AU - Ouldrouis, Taha AU - Lucas, Nadège AU - Allas, Soraya AU - Sumeray, Mark AU - Ovize, Michel AU - Mannstadt, Michael TI - An Open-Label Phase 2 Study of Eneboparatide, a Novel PTH Receptor 1 Agonist, in Hypoparathyroidism JF - JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM J2 - J CLIN ENDOCR METAB PY - 2024 SN - 0021-972X DO - 10.1210/clinem/dgae121 UR - https://m2.mtmt.hu/api/publication/34729561 ID - 34729561 AB - Hypoparathyroidism is a rare disorder characterized by a deficiency in parathyroid hormone (PTH) resulting in hypocalcemia, hyperphosphatemia, and hypercalciuria. Eneboparatide is an investigational peptide agonist of the PTH1 receptor for the treatment of chronic hypoparathyroidism (HP).To evaluate the efficacy, safety, and tolerability of eneboparatide in HP patients.Open-label, phase 2 study.Twenty-eight patients (21 women, 7 men), mean age (range): 58 years (28-72), with HP were enrolled into 2 consecutive cohorts (C1, n = 12, and C2, n = 16).Following an optimization period, daily subcutaneous injections of eneboparatide were administered for 3 months at 20 µg/day (C1) or 10 µg/day (C2) starting dose. Conventional therapy was progressively removed and eneboparatide could be titrated up to 60 µg (C1) or 80 µg (C2).Proportion of patients achieving independence from conventional therapy, albumin-adjusted serum calcium (ADsCa), 24-h urine calcium (uCa), serum bone turnover markers (s-CTX and P1NP), bone mineral density (BMD), and adverse events (AEs).After 3 months, ≥ 88% patients achieved independence from conventional therapy while mean ADsCa was maintained within target range (7.8-9 mg/dL). Eneboparatide induced a rapid and sustained reduction of mean 24-hour uCa, even among patients with hypercalciuria. Bone turnover markers slightly increased and BMD remained unchanged, consistent with progressive resumption of physiologic bone turnover. Eneboparatide was well tolerated with no serious AEs.Eneboparatide allowed independence from conventional therapy and maintenance of serum calcium within a target range, while normalizing uCa excretion and producing a balanced resumption of bone turnover. LA - English DB - MTMT ER - TY - JOUR AU - Tuttle, Katherine R AU - Hauske, Sibylle J AU - Canziani, Maria Eugenia AU - Caramori, Maria Luiza AU - Cherney, David AU - Cronin, Lisa AU - Heerspink, Hiddo J L AU - Hugo, Christian AU - Nangaku, Masaomi AU - Rotter, Ricardo Correa AU - Silva, Arnold AU - Shah, Shimoli V AU - Sun, Zhichao AU - Urbach, Dorothea AU - de Zeeuw, Dick AU - Rossing, Peter ED - Tuttle, Katherine R / Collaborator ED - Hauske, Sibylle J / Collaborator ED - Canziani, Maria Eugenia / Collaborator ED - Caramori, Maria Luiza / Collaborator ED - Cherney, David / Collaborator ED - Cronin, Lisa / Collaborator ED - Heerspink, Hiddo J L / Collaborator ED - Hugo, Christian / Collaborator ED - Nangaku, Masaomi / Collaborator ED - Rotter, Ricardo Correa / Collaborator ED - Silva, Arnold / Collaborator ED - Shah, Shimoli V / Collaborator ED - Sun, Zhichao / Collaborator ED - Urbach, Dorothea / Collaborator ED - de Zeeuw, Dick / Collaborator ED - Rossing, Peter / Collaborator ED - Szeto, Cheuk Chun / Collaborator ED - Echeverri, Diego / Collaborator ED - Martin, Edouard / Collaborator ED - Yee, Ming Li / Collaborator ED - Wah, William / Collaborator ED - Wang, Ray / Collaborator ED - Chacko, Bobby / Collaborator ED - Swaminathan, Shriram / Collaborator ED - MacIsaac, Richard / Collaborator ED - Hashimura, Hikaru / Collaborator ED - Ward, Glenn / Collaborator ED - De Vusser, Katrien / Collaborator ED - Claes, Kathleen / Collaborator ED - Kuypers, Dirk / Collaborator ED - Meijers, Björn / Collaborator ED - Van Craenenbroeck, Amaryllis / Collaborator ED - Hilbrands, Robert / Collaborator ED - Debroye, Corinne / Collaborator ED - Wissing, Karl Martin / Collaborator ED - Jadoul, Michel / Collaborator ED - Demoulin, Nathalie / Collaborator ED - Treille De Grandsaigne, Serge / Collaborator ED - Beklevic, Ishak / Collaborator ED - Marcoux, Diane / Collaborator ED - Liénart, Fabienne / Collaborator ED - Daper, Claude / Collaborator ED - De Brouckere, Véronique / Collaborator ED - Heureux, Mercédès / Collaborator ED - Felicio, Joao / Collaborator ED - Felicio, Karem Mileo / Collaborator ED - Leite, Daniella / Collaborator ED - Melo, Franciane / Collaborator ED - Queiroz, Natercia / Collaborator ED - Souza, Ana Carolina / Collaborator ED - Vieira, Jocyelle / Collaborator ED - Franco, Roberto / Collaborator ED - Mendes, Adriana / Collaborator ED - Picolli, Giovana / Collaborator ED - Canani, Luis Henrique / Collaborator ED - Sartori, Carla / Collaborator ED - Valenti, Adriana / Collaborator ED - Eliaschewitz, Freddy / Collaborator ED - Bona, Renata / Collaborator ED - Franco, Denise / Collaborator ED - Ludovico Costa de Castro, Denise / Collaborator ED - Magalhaes, Vanessa / Collaborator ED - Oliveira, Marcelo / Collaborator ED - Sampaio, Célia Regina / Collaborator ED - Visconti, Guilherme / Collaborator ED - Halpern, Bruno / Collaborator ED - Nihei, Camila / Collaborator ED - Pessoa, Bruna / Collaborator ED - Seraphim, Carlos / Collaborator ED - Santos, Daniel / Collaborator ED - Brito, Claudia / Collaborator ED - Douverny, Joao / Collaborator ED - Colella, Marina / Collaborator ED - Gazeta, Cristina / Collaborator ED - Vercia, Monique / Collaborator ED - Watanabe, Renato / Collaborator ED - Temelkova, Theodora / Collaborator ED - Kjurkchiev, Dimo / Collaborator ED - Statkova, Silviya / Collaborator ED - Popov, Iliya / Collaborator ED - Radeva, Radosveta / Collaborator ED - Arabadzhiev, Lachezar / Collaborator ED - Binova, Mariya / Collaborator ED - Bosilkov, Aleksandar / Collaborator ED - Koleva-Stoicheva, Neli / Collaborator ED - Ivanov, Ivaylo / Collaborator ED - Ivanova, Zornitsa / Collaborator ED - Kotseva, Viktoria / Collaborator ED - Spasov, Petar / Collaborator ED - Tsvetkov, Ivaylo / Collaborator ED - Jolly, Shivinder / Collaborator ED - Bailey, Gordon / Collaborator ED - Ye, Zhiming / Collaborator ED - Niu, Jianying / Collaborator ED - Li, Hongmei / Collaborator ED - Wu, Qing / Collaborator ED - Liao, Bing / Collaborator ED - Hao, Chuanming / Collaborator ED - Lai, Lingyun / Collaborator ED - Xu, Yunyu / Collaborator ED - Zhang, Min / Collaborator ED - Li, Yiwen / Collaborator ED - Liu, Bo / Collaborator ED - Shao, Lina / Collaborator ED - Chen, Wei / Collaborator ED - Wu, Haishan / Collaborator ED - Pirchala, Marian / Collaborator ED - Skarpova, Iva / Collaborator ED - Hraskova, Marketa / Collaborator ED - Soukupova, Simoneta / Collaborator ED - Veberova, Lucie / Collaborator ED - Drasnar, Tomas / Collaborator ED - Falc, Matej / Collaborator ED - Racz, Blazej / Collaborator ED - Votocek, Stepan / Collaborator ED - Weissova, Danica / Collaborator ED - Syc-Krivanova, Lenka / Collaborator ED - Slezak, Dagmar / Collaborator ED - Kantola, Ilkka / Collaborator ED - Nieminen, Sakari / Collaborator ED - Anttonen, Milla / Collaborator ED - Taurio, Jyrki / Collaborator ED - Lahtela, Jorma / Collaborator ED - Tsimihodimos, Vasileios / Collaborator ED - Balafa, Olga / Collaborator ED - Dounousi, Evangelia / Collaborator ED - Sakkou, Sissy / Collaborator ED - Tentolouris, Nikolaos / Collaborator ED - Siafarikas, Christos / Collaborator ED - Siami, Evangelia / Collaborator ED - Doupis, Ioannis / Collaborator ED - Angelopoulos, Theodoros / Collaborator ED - Georgoulias, Christodoulos / Collaborator ED - Pall, Denes / Collaborator ED - Esze, Regina / Collaborator ED - Kobling, Tamas / Collaborator ED - Varadi, Zita / Collaborator ED - Zsiros, Noemi / Collaborator ED - Vass, Viktor / Collaborator ED - Balo, Timea / Collaborator ED - Csanyi, Erika / Collaborator ED - Ory, Ivan / Collaborator ED - Pall, Istvan / Collaborator ED - Patai, Valentina / Collaborator ED - Zeak, Zsuzsanna / Collaborator ED - Takács, István / Collaborator ED - Pethő, Ákos / Collaborator ED - Szili, Balázs / Collaborator ED - Korányi, László / Collaborator ED - Bezzegh, Katalin / Collaborator ED - Pauer, Jozsef / Collaborator ED - Peterfai, Eva / Collaborator ED - Konyves, Laszlo / Collaborator ED - Szoke, Brigitta / Collaborator ED - Hajdu, Csaba / Collaborator ED - Kalman, Krisztina / Collaborator ED - Yadav, Raj / Collaborator ED - Saxena, Navneet / Collaborator ED - Bhattacharya, Meenakshi / Collaborator ED - Sharma, Bal / Collaborator ED - Thomas, Nihal / Collaborator ED - K, Felix Jebasingh / Collaborator ED - Kapoor, Nitin / Collaborator ED - Kurian, Mathews E / Collaborator ED - Paul, Jinson / Collaborator ED - Ramesh, Priyadharshini / Collaborator ED - Varghese, Sheeba / Collaborator ED - Shibusawa, Nobuyuki / Collaborator ED - Nishi, Hiroshi / Collaborator ED - Noritake, Nobuyasu / Collaborator ED - Oda, Takashi / Collaborator ED - Okamoto, Hideki / Collaborator ED - Kasuga, Hirotake / Collaborator ED - Hori, Hiroshi / Collaborator ED - Ito, Yukiko / Collaborator ED - Mizukoshi, Toshihiro / Collaborator ED - Ishii, Hideto / Collaborator ED - Han, Seung Hyeok / Collaborator ED - Kim, Hyung Woo / Collaborator ED - Oh, Kook-Hwan / Collaborator ED - Han, Seung Seok / Collaborator ED - Han, Sang Youb / Collaborator ED - Cha, Dae Ryong / Collaborator ED - Cha, Jin Joo / Collaborator ED - Kwon, Soon-Kil / Collaborator ED - Cho, Hyunjeong / Collaborator ED - Kim, Hye-Young / Collaborator ED - Kim, Sun Moon / Collaborator ED - Lee, Jung Pyo / Collaborator ED - Lee, Jeonghwan / Collaborator ED - Lee, Li Yuan / Collaborator ED - Chang, Meng Lee / Collaborator ED - Laang, Shian Tuck / Collaborator ED - Tan, Zhao Zhi / Collaborator ED - Ahmad Rosdi, Hajar / Collaborator ED - Mohammad Ismail, Siti Hafizah / Collaborator ED - Simatherai, Devamalar / Collaborator ED - Tay, Ju Fan / Collaborator ED - Wong, Eddie Fook Sem / Collaborator ED - Yakob, Suryati / Collaborator ED - Abdul Sukur, Noorhafini / Collaborator ED - Anuar, Amalina / Collaborator ED - Md Rasid, Syaliza / Collaborator ED - Mushaddik, Irma Liyana / Collaborator ED - Mustafar, Ruslinda / Collaborator ED - Abu Shamsi, Muhammad Yusuf / Collaborator ED - Fong, Voon Ken / Collaborator ED - Kamaruzaman, Lydia / Collaborator ED - Mohd, Rozita / Collaborator ED - Wan Daud, Wan Rohaslizan / Collaborator ED - Wan Hassan, Wan Hasnul Halimi / Collaborator ED - Ab Hamid, Suhaidarwani / Collaborator ED - Abdullah, Muhammad Nabil / Collaborator ED - Yusoff, Mohd Yusran / Collaborator ED - Ramanathan, G R Letchuman / Collaborator ED - Lee, Kim Yen / Collaborator ED - Wan Ismail, Wan Fadhilah / Collaborator ED - Morales Villegas, Enrique / Collaborator ED - Ramirez Baez, Rubria / Collaborator ED - Vital Lopez, Jorge / Collaborator ED - Arias Delgadillo, Cristhian / Collaborator ED - Herrera Marmolejo, Marisol / Collaborator ED - Parra Perez, Rosa / Collaborator ED - Alpizar Salazar, Melchor / Collaborator ED - Flores Montealegre, Ana / Collaborator ED - Galvan Magaña, Jose / Collaborator ED - Gutierrez Tlapale, Minerva / Collaborator ED - Reyes Munguia, Daniela / Collaborator ED - Witczak, Bartlomiej / Collaborator ED - Gøransson, Lasse / Collaborator ED - Strand Thorsen, Inga / Collaborator ED - Caringal, Clodoaido / Collaborator ED - Villardo, Mario / Collaborator ED - Toledo, Ronaldo / Collaborator ED - Dijamco, Emerlinda Fausto / Collaborator ED - De Asis, Norman Cornelio / Collaborator ED - Kuizon, Angelica / Collaborator ED - Catindig, Elizabeth Ann / Collaborator ED - Perez, Ronald / Collaborator ED - Aquitania, Grace / Collaborator ED - Pableo, Jimrie David / Collaborator ED - Sanchez, Jay Karlou / Collaborator ED - Czernecka, Ewa / Collaborator ED - Cegiel, Aleksandra / Collaborator ED - Knychas, Dorota / Collaborator ED - Ochnio, Malgorzata / Collaborator ED - Kuligowska-Jakubowska, Monika / Collaborator ED - Cesarz, Marek / Collaborator ED - Kowalewska-Celejewska, Milena / Collaborator ED - Masajtis-Zagajewska, Anna / Collaborator ED - Jankowski, Lukasz / Collaborator ED - Ojrzanowski, Marcin / Collaborator ED - Olszewska-Jander, Magdalena / Collaborator ED - Skokowska, Ewa / Collaborator ED - Giermakowska-Samek, Malgorzata / Collaborator ED - Luchowska, Elzbieta / Collaborator ED - Patkowska, Renata / Collaborator ED - Sekulska, Marzenna / Collaborator ED - Marczuk-Krynicka, Dorota / Collaborator ED - Marciniak, Andrzej / Collaborator ED - Barwijuk, Michal / Collaborator ED - Myslicki, Marcin / Collaborator ED - Siek, Michal / Collaborator ED - Wronska, Danuta / Collaborator ED - Tomsia-Goncerz, Jadwiga / Collaborator ED - Wronski, Krzysztof / Collaborator ED - Junik, Roman / Collaborator ED - Dzialak, Szymon / Collaborator ED - Kurlapska, Ewelina / Collaborator ED - Malecha, Wieslaw / Collaborator ED - Suwala, Szymon / Collaborator ED - Branco, Patrícia / Collaborator ED - Birne, Rita / Collaborator ED - Raposo, João / Collaborator ED - Ferreira, Marta / Collaborator ED - Alexandrino, Henrique / Collaborator ED - Alves, Helena / Collaborator ED - Correia, Sara / Collaborator ED - Oliveira, Maria João / Collaborator ED - Ramalho, Diogo / Collaborator ED - Tavares, Patricia / Collaborator ED - Coetzee, Kathleen / Collaborator ED - Blignaut, Sue / Collaborator ED - Viljoen, Winifred / Collaborator ED - Potgieter, Elsje / Collaborator ED - Malherbe, Elmien / Collaborator ED - Ortiz Arduán, Alberto / Collaborator ED - Goma Garcés, Elena / Collaborator ED - Pérez, María / Collaborator ED - Santamaría, Rafael / Collaborator ED - López López, Isabel / Collaborator ED - Pendón de Mier, Victoria / Collaborator ED - Rodelo Haad, Cristian / Collaborator ED - Marques, María / Collaborator ED - Domènech, Esther / Collaborator ED - Portoles, Josep Maria / Collaborator ED - Soler, María José / Collaborator ED - Agraz, Irene / Collaborator ED - Azancot, María Antonieta / Collaborator ED - Bermejo, Sheila / Collaborator ED - Bolufer, Mónica / Collaborator ED - López, Marina / Collaborator ED - Ramos, Natalia / Collaborator ED - Toapanta, Néstor / Collaborator ED - Cigarrán Guldris, Secundino / Collaborator ED - Primo, Juan Carlos / Collaborator ED - Pérez, Luis Enrique / Collaborator ED - Rebollido Fernández, María / Collaborator ED - Holmer, Helene / Collaborator ED - Bruchfeld, Annette / Collaborator ED - Rofors, Justus / Collaborator ED - Tengmark, Bengt-Olov / Collaborator ED - Wuerzner, Gregoire / Collaborator ED - Leanizbarrutia, Garazi / Collaborator ED - Ozturk, Savas / Collaborator ED - Guler, Nurana / Collaborator ED - Safak, Seda / Collaborator ED - Lee, Keung / Collaborator ED - Campbell, Stephen / Collaborator ED - Siddiqui, Imran / Collaborator ED - Abbasi, Nadia / Collaborator ED - Tahir, Faiza / Collaborator ED - Azizad, Masoud / Collaborator ED - Jackson, Timothy / Collaborator ED - Everhart, Brian / Collaborator ED - Oliver, Michael / Collaborator ED - Rust, William / Collaborator ED - Sniezek, Matthew / Collaborator ED - Arif, Ahmed / Collaborator ED - Syed, Mohammed / Collaborator ED - Bhasin, Nitin / Collaborator ED - Bien, Michael / Collaborator ED - Gallego, Claudio / Collaborator ED - Jamal, Aamir / Collaborator ED - Moghadam, Mojtaba / Collaborator ED - Rizvi, Abid / Collaborator ED - Rizvi, Amna / Collaborator ED - Rizvi, Syed / Collaborator ED - Wong, Christopher / Collaborator ED - Lucas, Kathryn / Collaborator ED - Buery, Andrea / Collaborator ED - Chang, Ku-Lang / Collaborator ED - Presswood, Claire / Collaborator ED - Smith, Justin / Collaborator ED - Doshi, Ankur / Collaborator ED - Parikh, Manish / Collaborator ED - Wallace, Jeannine / Collaborator ED - Krishna, Arvind / Collaborator ED - Daugherty, Heidi / Collaborator ED - Fearday, Aaron / Collaborator ED - Keller, Christopher / Collaborator ED - Meng, Jerry / Collaborator ED - Nielsen, Alexandra / Collaborator ED - Rovner, Sergio / Collaborator ED - Almeida, Javier / Collaborator ED - Marranzini, Benito / Collaborator ED - Selby, Lisa / Collaborator ED - Yablon, Zachary / Collaborator ED - Jean-Louis, Daphne / Collaborator ED - Kotzker, Wayne / Collaborator ED - Perez, Chabely / Collaborator ED - Richards, Marc / Collaborator ED - Rosario, Reinaldo / Collaborator ED - Marcus, Roy / Collaborator ED - Okechukwu, Chike / Collaborator ED - Ross, Dennis / Collaborator ED - Gromala, Rachel / Collaborator ED - Reed, Matthew / Collaborator ED - Weber, Lisa / Collaborator ED - Nazeer, Imran / Collaborator ED - Kumar, Prashant / Collaborator ED - Mir, Muhammad / Collaborator ED - Shea, Heidi / Collaborator ED - Hart, Amanda / Collaborator ED - Wiebel, Jaime / Collaborator ED - Kooienga, Laura / Collaborator ED - Newsome, Britt / Collaborator ED - Suyumova, Irina / Collaborator ED - Alvarez, German / Collaborator ED - Bireddy, Venkata / Collaborator ED - Lansang, Maria / Collaborator ED - Mandry, Jose / Collaborator ED - Freire, Maria / Collaborator ED - Herrera Albornoz, Oscarina / Collaborator ED - Desai, Anant / Collaborator ED - Gandhi, Dayan / Collaborator ED - Rajan, Sibu / Collaborator ED - Raymond, Louis / Collaborator ED - Posada, Jorge / Collaborator ED - Garcia-Mayol, Luis / Collaborator ED - Gutierrez-Alsina, Rodolfo / Collaborator ED - Fernandez, Juan / Collaborator ED - Bruce, Kendaling / Collaborator ED - Cuellar, Juan / Collaborator ED - Ranz Y Alvarez, Maria / Collaborator ED - Bartolacci, Ines / Collaborator ED - Pautasso, Mauro / Collaborator ED - Stoppa, Daniela / Collaborator ED - Riella, Miguel / Collaborator ED - Barbosa, Maria / Collaborator ED - Harcsa, Eleonora / Collaborator ED - Gulati, Yuvraj / Collaborator ED - Savalia, Denish / Collaborator ED - Khetan, Prakash / Collaborator ED - Sinha, Dhananjay / Collaborator ED - R, Niranjan / Collaborator ED - K, Srinivas / Collaborator ED - Pazos, Fabiola / Collaborator ED - Gacutan-Liwag, Aretha / Collaborator ED - Duszynska, Malgorzata / Collaborator ED - Antkowiak-Piatyszek, Karolina / Collaborator ED - Konieczny, Grzegorz / Collaborator ED - Sidorowicz-Bialynicka, Anna / Collaborator ED - Ciesiolkiewicz-Wojcik, Agnieszka / Collaborator ED - Dwojak, Marek / Collaborator ED - Szymkowiak, Katarzyna / Collaborator ED - Gorczyca-Siudak, Daria / Collaborator ED - Janik-Palazzolo, Marzena / Collaborator ED - Siudak, Lukasz / Collaborator ED - Opiela, Jaroslaw / Collaborator ED - Iwanow, Dariusz / Collaborator ED - Solkiewicz, Monika / Collaborator ED - Sipinska-Surzynska, Malgorzata / Collaborator ED - Olszanecka-Glinianowicz, Magdalena / Collaborator ED - Rozmilowska, Izabela / Collaborator ED - Trokis, Julian / Collaborator ED - Prozesky, Hans / Collaborator ED - Burgess, Lesley / Collaborator ED - Cyster, Henry / Collaborator ED - Jordaan, Jurie / Collaborator ED - Mohamed, Hawa / Collaborator ED - Naude, Christina / Collaborator ED - Sitsila, Thembie / Collaborator ED - Mehta, Arvind / Collaborator ED - Mocherla, Bharat / Collaborator ED - Lee, Sungchun / Collaborator ED - Boren, Kenneth / Collaborator ED - Rudolph, Lance / Collaborator ED - Benjamin, Sabrina / Collaborator ED - Sugimoto, Danny / Collaborator ED - Hammoud, Jamal / Collaborator ED - Bakleh, Muhammad / Collaborator ED - Hashish, Yaseen / Collaborator ED - Da Costa, Jonathan / Collaborator ED - Gold, Marina / Collaborator ED - Majul, Claudio / Collaborator ED - Buscema, Juan / Collaborator ED - Gatto, Maria / Collaborator ED - Lombardi, Facundo / Collaborator ED - Paez, Olga / Collaborator ED - Puleio, Pablo / Collaborator ED - Alvarisqueta, Andrés / Collaborator ED - Pajon, Vanessa / Collaborator ED - Suarez, Gabriel / Collaborator ED - Hernandez Gauna, Adrian / Collaborator ED - Pereyra, Alejandro / Collaborator ED - Reig, Moira / Collaborator ED - Gelersztein, Elizabeth / Collaborator ED - Campestri, Gina / Collaborator ED - Gonzalez Santos, Maria / Collaborator ED - Sambresqui, Julieta / Collaborator ED - Catalano, Gustavo / Collaborator ED - Igarzabal, Cecilia / Collaborator ED - Vallejos, Augusto / Collaborator ED - Escobari, Claudio / Collaborator ED - Marchetto, Rocio / Collaborator ED - Chahin, Mariano / Collaborator ED - Aguilera, Andrea / Collaborator ED - Comes, Ana / Collaborator ED - Rodriguez Segade, Silvia / Collaborator ED - Baccaro, Claudia / Collaborator ED - Larrieu Lacoste, María Verónica / Collaborator ED - Saurral, Ruben / Collaborator ED - Cristino, Alberto / Collaborator ED - Dran, Dario / Collaborator ED - Koretzky, Martin / Collaborator ED - Ponti, Juan / Collaborator ED - Porto, Alejandro / Collaborator ED - Tenaglia, Yasmin / Collaborator ED - Maldonado, Natacha / Collaborator ED - Bertollo, Natalia / Collaborator ED - Van Perdeck, Verónica / Collaborator ED - Lopau, Kai / Collaborator ED - Wanner, Christoph / Collaborator ED - Berfelo, Florieke / Collaborator ED - Contzen, Christel / Collaborator ED - Arbi, Abdulwahab / Collaborator ED - Lee-Barkey, Young Hee / Collaborator ED - Maciejewska, Aleksandra / Collaborator ED - Arelin, Katrin / Collaborator ED - Haller, Hermann / Collaborator ED - Kaufeld, Jessica / Collaborator ED - Schmidt-Ott, Kai / Collaborator ED - Heinrichs, Sven / Collaborator ED - Krüger, Thilo / Collaborator ED - Gebauer, Chris / Collaborator ED - Paliege, Alexander / Collaborator ED - Henkel, Elena / Collaborator ED - Axthelm, Christoph / Collaborator ED - Derwahl, Karl-Michael / Collaborator ED - Trevisan, Roberto / Collaborator ED - Bellante, Rosalia / Collaborator ED - Borrella, Nicolò / Collaborator ED - Corsi, Anna / Collaborator ED - Gesualdo, Loreto / Collaborator ED - Ardillo, Teodora / Collaborator ED - Ficarella, Maria / Collaborator ED - Fikry, Sameh / Collaborator ED - Mazza, Giuseppe / Collaborator ED - Poirier, Lysane / Collaborator ED - Bajaj, Harpreet / Collaborator ED - Hatziagelaki, Erifili / Collaborator ED - Katopodis, Sokratis / Collaborator ED - Katsoudas, Spiros / Collaborator ED - Yamaura, Shuichi / Collaborator ED - Shikano, Tsutomu / Collaborator ED - Tosaki, Takahiro / Collaborator ED - Miho, Otoya / Collaborator ED - Tachibana, Naoki / Collaborator ED - Yumita, Wataru / Collaborator ED - Kado, Hiroshi / Collaborator ED - Villarreal Martinez, Jesus / Collaborator ED - Soto Miranda, Ernesto / Collaborator ED - Gonzalez Rodriguez, David / Collaborator ED - Panelo, Araceli / Collaborator ED - Santos, Telma / Collaborator ED - Birne, Rita / Collaborator ED - Branco, Patrícia / Collaborator ED - Martins, Ana / Collaborator ED - Mateus, Catarina / Collaborator ED - Teixeira E Costa, Fernando / Collaborator ED - Barreto, Sara / Collaborator ED - Silva Costa, Joana / Collaborator ED - Ferrer, Francisco / Collaborator ED - Silva, Joana / Collaborator ED - Awad, Ahmed / Collaborator ED - Khaleel, Shatha / Collaborator ED - Lustig, Ryan / Collaborator ED - Maharjan, Gajendra / Collaborator ED - Moya, Jaynier / Collaborator ED - Johnsingh, Amit / Collaborator ED - Acosta, Idalia / Collaborator ED - Newman, George / Collaborator ED - Buckle, Anita / Collaborator ED - Hendon, Kendra / Collaborator TI - Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease. a randomised, controlled, phase 2 trial TS - a randomised, controlled, phase 2 trial JF - LANCET J2 - LANCET VL - 403 PY - 2024 IS - 10424 SP - 379 EP - 390 PG - 12 SN - 0140-6736 DO - 10.1016/S0140-6736(23)02408-X UR - https://m2.mtmt.hu/api/publication/34452050 ID - 34452050 AB - Excess aldosterone accelerates chronic kidney disease progression. This phase 2 clinical trial assessed BI 690517, an aldosterone synthase inhibitor, for efficacy, safety, and dose selection.This was a multinational, randomised, controlled, phase 2 trial. People aged 18 years or older with an estimated glomerular filtration rate (eGFR) of 30 to less than 90 mL/min/1·73 m2, a urine albumin to creatinine ratio (UACR) of 200 to less than 5000 mg/g, and serum potassium of 4·8 mmol/L or less, taking an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker, were enrolled. Participants were randomly assigned (1:1) to 8 weeks of empagliflozin or placebo run-in, followed by a second randomisation (1:1:1:1) to 14 weeks of treatment with once per day BI 690517 at doses of 3 mg, 10 mg, or 20 mg, or placebo. Study participants, research coordinators, investigators, and the data coordinating centre were masked to treatment assignment. The primary endpoint was the change in UACR measured in first morning void urine from baseline (second randomisation) to the end of treatment. This study is registered with ClinicalTrials.gov (NCT05182840) and is completed.Between Feb 18 and Dec 30, 2022, of the 714 run-in participants, 586 were randomly assigned to receive BI 690517 or placebo. At baseline, 33% (n=196) were women, 67% (n=390) were men, 42% (n=244) had a racial identity other than White, and mean participant age was 63·8 years (SD 11·3). Mean baseline eGFR was 51·9 mL/min/1·73 m2 (17·7) and median UACR was 426 mg/g (IQR 205 to 889). Percentage change in first morning void UACR from baseline to the end of treatment at week 14 was -3% (95% CI -19 to 17) with placebo, -22% (-36 to -7) with BI 690517 3 mg, -39% (-50 to -26) with BI 690517 10 mg, and -37% (-49 to -22) with BI 690517 20 mg monotherapy. BI 690517 produced similar UACR reductions when added to empagliflozin. Investigator-reported hyperkalaemia occurred in 10% (14/146) of those in the BI 690517 3 mg group, 15% (22/144) in the BI 690517 10 mg group, and 18% (26/146) in the BI 690517 20 mg group, and in 6% (nine of 147) of those receiving placebo, with or without empagliflozin. Most participants with hyperkalaemia did not require intervention (86% [72/84]). Adrenal insufficiency was an adverse event of special interest reported in seven of 436 study participants (2%) receiving BI 690517 and one of 147 participants (1%) receiving matched placebo. No treatment-related deaths occurred during the study.BI 690517 dose-dependently reduced albuminuria with concurrent renin-angiotensin system inhibition and empagliflozin, suggesting an additive efficacy for chronic kidney disease treatment without unexpected safety signals.Boehringer Ingelheim. LA - English DB - MTMT ER - TY - JOUR AU - Ungvári, Zoltán István AU - Tabák, Ádám AU - Ádány, Róza AU - Purebl, György AU - Kaposvári, Csilla AU - Fazekas-Pongor, Vince AU - Csípő, Tamás AU - Szarvas, Zsófia AU - Horváth, Krisztián AU - Mukli, Péter AU - Balog, Piroska AU - Bódizs, Róbert AU - Ujma, Przemyslaw Péter AU - Stauder, Adrienne AU - Belsky, Daniel W. AU - Kovács, Illés AU - Yabluchanskiy, Andriy AU - Maier, Andrea B. AU - Moizs, Mariann AU - Östlin, Piroska AU - Yon, Yongjie AU - Varga, Péter AU - Vokó, Zoltán AU - Papp, Magor Csongor AU - Takács, István AU - Vásárhelyi, Barna AU - Torzsa, Péter AU - Ferdinandy, Péter AU - Csiszar, Anna AU - Benyó, Zoltán AU - Szabó, Attila AU - Bednárikné Dörnyei, Gabriella AU - Kivimäki, Mika AU - Kellermayer, Miklós AU - Merkely, Béla Péter TI - The Semmelweis Study: a longitudinal occupational cohort study within the framework of the Semmelweis Caring University Model Program for supporting healthy aging JF - GEROSCIENCE: OFFICIAL JOURNAL OF THE AMERICAN AGING ASSOCIATION (AGE) J2 - GEROSCIENCE VL - 46 PY - 2024 IS - 1 SP - 191 EP - 218 PG - 28 SN - 2509-2715 DO - 10.1007/s11357-023-01018-7 UR - https://m2.mtmt.hu/api/publication/34425939 ID - 34425939 N1 - International Training Program in Geroscience/Healthy Aging Program, Doctoral School of Basic and Translational Medicine/Department of Public Health, Semmelweis University, Budapest, Hungary Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States Department of Health Promotion Sciences, The Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States Department of Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary UCL Brain Sciences, University College London, London, United Kingdom Department of Internal Medicine and Oncology, Semmelweis University, Faculty of Medicine, Budapest, Hungary HUN-REN-UD Public Health Research Group, Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary Institute of Behavioral Sciences, Faculty of Medicine, Semmelweis University, Budapest, Hungary Robert N. Butler Columbia Aging Center, Columbia University, New York, NY, United States Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, United States Department of Ophthalmology, Faculty of Medicine, Semmelweis University, Budapest, Hungary Department of Ophthalmology, Weill Cornell Medical College, New York City, NY, United States Department of Clinical Ophthalmology, Faculty of Health Sciences, Semmelweis University, Budapest, Hungary Healthy Longevity Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore Centre for Healthy Longevity, National University Health System, Singapore, Singapore Department of Human Movement Sciences, @AgeAmsterdam, Vrije Universiteit, Amsterdam Movement Sciences, Amsterdam, Netherlands Ministry of Interior of Hungary, Budapest, Hungary WHO Regional Office for Europe, Copenhagen, Denmark Clinical Center, Semmelweis University, Budapest, Hungary Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary Department of Laboratory Medicine, Faculty of Medicine, Semmelweis University, Budapest, Hungary Department of Family Medicine, Faculty of Medicine, Semmelweis University, Budapest, Hungary Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Budapest, Hungary Department of Translational Medicine, Faculty of Medicine, Semmelweis University, Budapest, Hungary HUN-REN-SU Cerebrovascular and Neurocognitive Diseases Research Group, Budapest, Hungary First Department of Pediatrics, Faculty of Medicine, Semmelweis University, Budapest, Hungary HUN-REN-SU Pediatrics and Nephrology Research Group, Semmelweis University, Budapest, Hungary Department of Morphology and Physiology, Faculty of Health Sciences, Semmelweis University, Budapest, Hungary Department of Biophysics and Radiation Biology, Faculty of Medicine, Semmelweis University, Budapest, Hungary Heart and Vascular Center, Semmelweis University, Budapest, Hungary Cited By :1 Export Date: 29 February 2024 Correspondence Address: Ungvari, Z.; International Training Program in Geroscience/Healthy Aging Program, Hungary; email: Zoltan-Ungvari@ouhsc.edu Correspondence Address: Adany, R.; International Training Program in Geroscience/Healthy Aging Program, Hungary AB - The Semmelweis Study is a prospective occupational cohort study that seeks to enroll all employees of Semmelweis University (Budapest, Hungary) aged 25 years and older, with a population of 8866 people, 70.5% of whom are women. The study builds on the successful experiences of the Whitehall II study and aims to investigate the complex relationships between lifestyle, environmental, and occupational risk factors, and the development and progression of chronic age-associated diseases. An important goal of the Semmelweis Study is to identify groups of people who are aging unsuccessfully and therefore have an increased risk of developing age-associated diseases. To achieve this, the study takes a multidisciplinary approach, collecting economic, social, psychological, cognitive, health, and biological data. The Semmelweis Study comprises a baseline data collection with open healthcare data linkage, followed by repeated data collection waves every 5 years. Data are collected through computer-assisted self-completed questionnaires, followed by a physical health examination, physiological measurements, and the assessment of biomarkers. This article provides a comprehensive overview of the Semmelweis Study, including its origin, context, objectives, design, relevance, and expected contributions. LA - English DB - MTMT ER -